1.Epidemiological investigation and analysis of a local dengue fever cluster outbreak in Qingpu District of Shanghai
Changpo LIN ; Wei WANG ; Zhangrui XU ; Yadong MA ; Zhicheng ZHANG ; Xueqin YU ; Chengcheng WANG ; Haoxuan WANG ; Yanli DAI ; Huanyu WU
Shanghai Journal of Preventive Medicine 2026;38(3):206-209
ObjectiveTo analyze the epidemiological characteristics of a local dengue fever cluster outbreak in Qingpu District of Shanghai in 2024, and to provide a reference for subsequent dengue fever prevention and control. MethodsSeven confirmed local dengue fever cases reported through the National Notifiable Infectious Diseases Surveillance System in Qingpu District of Shanghai in 2024 were selected as the research subjects. Descriptive epidemiological methods were used to conduct investigation and analysis from the aspects of onset, medical treatment and reporting, clinical symptoms, travel and contact history within 15 days before onset, and activity trajectories. ResultsA total of 7 cases were identified in this outbreak. None of the cases had a travel history to dengue-endemic areas within 15 days prior to onset, while all had shared exposure environments and mosquito bite histories, indicating a local clustered transmission pattern. The main clinical manifestations included fever (100.00%) and myalgia (42.86%). All 7 cases were positive for dengue virus serotype 2 (DENV-2) by nucleic acid testing. Genetic sequencing showed that the virus strains belonged to the Cosmopolitan genotype and were most closely related to the epidemic DENV strains circulating in southern China in recent years. ConclusionThis outbreak might be a local secondary infection caused by the short-term stay of dengue fever-infected individuals, and the possible source of importation was dengue fever endemic areas in southern China.
2.Analysis of Factors Influencing Early Postpartum Pelvic Floor Muscle Strength Following Cesarean Delivery
Huanyu LIN ; Min YU ; Xuhong LU
Journal of Practical Obstetrics and Gynecology 2025;41(5):419-424
Objective:To identify the risk factors associated with early postpartum pelvic floor muscle strength following cesarean delivery.Methods:A total of 352 women who underwent cesarean section at the Department of Obstetrics and Gynecology,Affiliated Zhongshan Hospital of Dalian University between September 2022 and Sep-tember 2024 and attended a pelvic floor rehabilitation clinic 6 to 8 weeks postpartum were enrolled in this study,and lectromyographic(EMG)values during anterior and posterior resting phases,as well as fast-twitch and slow-twitch muscle phases,were recorded so as to analyze the factors that might affect the pelvic floor strength in the early postnatal period after cesarean section.Factors with statistically significant differences were further ana-lyzed by multifactorial Logistic analysis.Results:Pre-pregnancy body mass index(BMI)>24 kg/m2,increase in body mass during pregnancy ≥ 11.5 kg,gestational hypertension and term delivery were identified as independent risk factors for abnormal EMG values during the anterior resting phase of the pelvic floor(OR>1,P<0.05).In-crease in body mass during pregnancy≥11.5 kg,preterm rupture of membranes,and term delivery were risk fac-tors for abnormal pelvic floor EMG values in the post-resting stage(OR>1,P<0.05).Pre-pregnancy BMI>24 kg/m2 and pre-eclampsia were risk factors for abnormal pelvic floor EMG values in the fast-muscle stage(OR>1,P<0.05).and a history of uterine fibroids was a risk factor for abnormal pelvic floor EMG values in the slow-muscle stage(OR>1,P<0.05).Conclusions:Early postpartum pelvic floor muscle strength following ce-sarean delivery is influenced by several risk factors,including pre-pregnancy BMI>24 kg/m2,increase in body mass during pregnancy ≥ 11.5 kg,gestational hypertension,full-term labor,premature rupture of membranes,pre-eclampsia,and history of uterine fibroids,pelvic floor muscle strength is more likely to be impaired in the early postpartum period after the prenatal combination of the above risk factors,and Targeted pelvic floor rehabilitation should be initiated as early as possible during the postpartum period.
3.Development of a Nomogram Prediction Model for Postoperative Recurrence of Ovarian Endometriosis after Conservative Surgery
Miao YU ; Jinchai ZHAO ; Huanyu JIN ; Congyu ZHOU ; Lin ZHANG ; Yanfang DU
Journal of Practical Obstetrics and Gynecology 2025;41(4):341-345
Objective:The prediction model of postoperative recurrence of ovarian endometriosis cyst(OEM)was constructed to provide a reference for evaluating postoperative recurrence of OEM patients.Methods:The clinical,pathological and follow-up data of 342 patients who underwent the initial laparoscopic ovarian cystectomy for OEM at The Second Hospital of Hebei Medical University from January 1,2017 to October 31,2021 were retro-spectively analyzed.Based on univariate and multivariate Cox regression analysis,the relevant factors affecting OEM recurrence were identified.According to the results of multivariate analysis,a nomogram was drawn.The C index and receiver operating characteristic(ROC)curve were used to test the efficiency of the prediction model.Results:The 2-year recurrence rate of OEM patients was 20.4%and the 5-year recurrence rate was 35.2%.Uni-variate and multivariate Cox regression analysis showed that menstrual cycle(HR 0.916,95%CI 0.860-0.976,P=0.006),delivery≥1(HR 0.376,95%CI 0.171-0.827,P=0.015),CA125≥100 U/ml(HR 1.790,95%CI 1.167-2.746,P=0.008),total cyst diameter≥10 cm(HR 2.254,95%CI 1.318-3.854,P=0.003),and postoperative medications(HR 0.434,95%CI 0.292-0.644,P=0.000)were associated with OEM recurrence and were included in the no-mogram prediction model.The C-index of the nomogram prediction model was 0.710(95%CI 0.665-0.754),and the area under the curve(AUC)of the ROC for OEM patients with recurrence at 2 years after surgery was 0.786 and 0.708 at 5 years.Conclusions:In this study,we developed a nomogram to predict the probability of recur-rence at 2 years and 5 years for OEM patients under 45 years who underwent conservative surgery,which has i-deal predictive performance and helps clinicians to screen high-risk patients,and thus give high-risk OEM patients additional attention and intervention.
4.Development of a Nomogram Prediction Model for Postoperative Recurrence of Ovarian Endometriosis after Conservative Surgery
Miao YU ; Jinchai ZHAO ; Huanyu JIN ; Congyu ZHOU ; Lin ZHANG ; Yanfang DU
Journal of Practical Obstetrics and Gynecology 2025;41(4):341-345
Objective:The prediction model of postoperative recurrence of ovarian endometriosis cyst(OEM)was constructed to provide a reference for evaluating postoperative recurrence of OEM patients.Methods:The clinical,pathological and follow-up data of 342 patients who underwent the initial laparoscopic ovarian cystectomy for OEM at The Second Hospital of Hebei Medical University from January 1,2017 to October 31,2021 were retro-spectively analyzed.Based on univariate and multivariate Cox regression analysis,the relevant factors affecting OEM recurrence were identified.According to the results of multivariate analysis,a nomogram was drawn.The C index and receiver operating characteristic(ROC)curve were used to test the efficiency of the prediction model.Results:The 2-year recurrence rate of OEM patients was 20.4%and the 5-year recurrence rate was 35.2%.Uni-variate and multivariate Cox regression analysis showed that menstrual cycle(HR 0.916,95%CI 0.860-0.976,P=0.006),delivery≥1(HR 0.376,95%CI 0.171-0.827,P=0.015),CA125≥100 U/ml(HR 1.790,95%CI 1.167-2.746,P=0.008),total cyst diameter≥10 cm(HR 2.254,95%CI 1.318-3.854,P=0.003),and postoperative medications(HR 0.434,95%CI 0.292-0.644,P=0.000)were associated with OEM recurrence and were included in the no-mogram prediction model.The C-index of the nomogram prediction model was 0.710(95%CI 0.665-0.754),and the area under the curve(AUC)of the ROC for OEM patients with recurrence at 2 years after surgery was 0.786 and 0.708 at 5 years.Conclusions:In this study,we developed a nomogram to predict the probability of recur-rence at 2 years and 5 years for OEM patients under 45 years who underwent conservative surgery,which has i-deal predictive performance and helps clinicians to screen high-risk patients,and thus give high-risk OEM patients additional attention and intervention.
5.Analysis of Factors Influencing Early Postpartum Pelvic Floor Muscle Strength Following Cesarean Delivery
Huanyu LIN ; Min YU ; Xuhong LU
Journal of Practical Obstetrics and Gynecology 2025;41(5):419-424
Objective:To identify the risk factors associated with early postpartum pelvic floor muscle strength following cesarean delivery.Methods:A total of 352 women who underwent cesarean section at the Department of Obstetrics and Gynecology,Affiliated Zhongshan Hospital of Dalian University between September 2022 and Sep-tember 2024 and attended a pelvic floor rehabilitation clinic 6 to 8 weeks postpartum were enrolled in this study,and lectromyographic(EMG)values during anterior and posterior resting phases,as well as fast-twitch and slow-twitch muscle phases,were recorded so as to analyze the factors that might affect the pelvic floor strength in the early postnatal period after cesarean section.Factors with statistically significant differences were further ana-lyzed by multifactorial Logistic analysis.Results:Pre-pregnancy body mass index(BMI)>24 kg/m2,increase in body mass during pregnancy ≥ 11.5 kg,gestational hypertension and term delivery were identified as independent risk factors for abnormal EMG values during the anterior resting phase of the pelvic floor(OR>1,P<0.05).In-crease in body mass during pregnancy≥11.5 kg,preterm rupture of membranes,and term delivery were risk fac-tors for abnormal pelvic floor EMG values in the post-resting stage(OR>1,P<0.05).Pre-pregnancy BMI>24 kg/m2 and pre-eclampsia were risk factors for abnormal pelvic floor EMG values in the fast-muscle stage(OR>1,P<0.05).and a history of uterine fibroids was a risk factor for abnormal pelvic floor EMG values in the slow-muscle stage(OR>1,P<0.05).Conclusions:Early postpartum pelvic floor muscle strength following ce-sarean delivery is influenced by several risk factors,including pre-pregnancy BMI>24 kg/m2,increase in body mass during pregnancy ≥ 11.5 kg,gestational hypertension,full-term labor,premature rupture of membranes,pre-eclampsia,and history of uterine fibroids,pelvic floor muscle strength is more likely to be impaired in the early postpartum period after the prenatal combination of the above risk factors,and Targeted pelvic floor rehabilitation should be initiated as early as possible during the postpartum period.
6.Epidemic characteristics and spatial distribution of vomiting and diarrhea outbreaks in schools and kindergartens in Shanghai from 2015 to 2019
GONG Xiaohuan, XIAO Wenjia, ZHENG Yaxu, LIN Sheng, YU Xiao, WU Huanyu, CHEN Jian, PAN Hao
Chinese Journal of School Health 2024;45(10):1476-1480
Objective:
To retrospectively analyze the epidemic characteristics and spatial distribution of vomiting and diarrhea outbreaks in schools and kindergartens in Shanghai from 2015 to 2019, so as to provide the scientific evidence for optimizing prevention and control of vomiting and diarrhea outbreaks in schools and kindergartens.
Methods:
Data collection and analysis were carried out on the vomiting and diarrhea outbreaks reported to Shanghai Municipal Center for Disease Control and Prevention from 2015 to 2019. Epidemiological characteristics were analyzed and compared. The proportion and incidence of outbreaks in schools and kindergartens were calculated, and the influencing factors of outbreaks were analyzed by multivariate Logistic regression. The index of Moran s I was used for the global and local spatial auto correlation analysis.
Results:
Among the 344 vomiting and diarrhea outbreaks, 98.26% occurred in kindergartens, primary schools, middle schools and other educational institutions. The median number of cases per outbreak was 15. The number of suspected outbreaks and the percentage of cases involved peaked in 2015 ( 60.00% , 84.35%) and then decreased year by year to 16.00% and 38.80% in 2019. About 86.98% of the outbreaks were transmitted by human to human contact. Among the 329 outbreaks with samples collected from cases and/or environments, the main pathogen detected was norovirus ( n =280), and sapovirus was detected in outbreak for the first time in 2016. The outbreaks showed obvious seasonality, with two peaks (November, March) and one trough (July), and the majority of outbreaks occurred in primary schools (44.38%) and kindergartens (32.84%). Compared with kindergartens, the probabilities of suspected epidemic outbreaks in primary schools, combined schools, middle schools and other educational institutions were higher (adjusted OR =6.40, 9.16, 12.64 , 5.58, P <0.01). The proportion and incidence of outbreaks in educational institutions in different districts showed no high-high aggregation areas.
Conclusions
Primary schools and kindergartens are key places for the prevention and control of vomiting and diarrhea outbreaks. Targeted prevention and control measures should be strengthened at the beginning of each semester and before the peak of the epidemic each year. Timely reporting of symptoms, suspension of school admissions after symptoms appear and standardized disposal of vomit are effective measures to reduce interpersonal transmission and control the scale of an outbreak.
7.A Potential Novel Targeted Drug for the Treatment of Pulmonary Arterial Hypertension:Imatinib
Shanshan XIE ; Ye LI ; Lingling YU ; Jinjin WAN ; Zhiying HUANG ; Huanyu LIN ; Weifang ZHANG
Herald of Medicine 2024;43(2):262-266
Pulmonary hypertension has a high mortality rate,and although targeted therapy is available,it is still incurable,and the long-term prognosis for patients is poor.As a tyrosine kinase inhibitor,imatinib was approved for marketing in China in 2002 for the treatment of chronic myelogenous leukemia and other tumor diseases.In addition to the antitumor effects,imatinib was found to improve hemodynamics and exercise tolerance in patients with severe pulmonary arterial hypertension,but the safety was suboptimal.With the emergence of new formulations of imatinib targeted at the lungs,it is expected to become a new targeted drug for pulmonary arterial hypertension.
8.Efficacy evaluation of extending or switching to tenofovir amibufenamide in patients with chronic hepatitis B: a phase Ⅲ randomized controlled study
Zhihong LIU ; Qinglong JIN ; Yuexin ZHANG ; Guozhong GONG ; Guicheng WU ; Lvfeng YAO ; Xiaofeng WEN ; Zhiliang GAO ; Yan HUANG ; Daokun YANG ; Enqiang CHEN ; Qing MAO ; Shide LIN ; Jia SHANG ; Huanyu GONG ; Lihua ZHONG ; Huafa YIN ; Fengmei WANG ; Peng HU ; Xiaoqing ZHANG ; Qunjie GAO ; Chaonan JIN ; Chuan LI ; Junqi NIU ; Jinlin HOU
Chinese Journal of Hepatology 2024;32(10):883-892
Objective:In chronic hepatitis B (CHB) patients with previous 96-week treatment with tenofovir amibufenamide (TMF) or tenofovir disoproxil fumarate (TDF), we investigated the efficacy of sequential TMF treatment from 96 to 144 weeks.Methods:Enrolled subjects who were previously assigned (2:1) to receive either 25 mg TMF or 300 mg TDF with matching placebo for 96 weeks received extended or switched TMF treatment for 48 weeks. Efficacy was evaluated based on virological, serological, biological parameters, and fibrosis staging. Statistical analysis was performed using the McNemar test, t-test, or Log-Rank test according to the data. Results:593 subjects from the initial TMF group and 287 subjects from the TDF group were included at week 144, with the proportions of HBV DNA<20 IU/ml at week 144 being 86.2% and 83.3%, respectively, and 78.1% and 73.8% in patients with baseline HBV DNA levels ≥8 log10 IU/ml. Resistance to tenofovir was not detected in both groups. For HBeAg loss and seroconversion rates, both groups showed a further increase from week 96 to 144 and the 3-year cumulative rates of HBeAg loss were about 35% in each group. However, HBsAg levels were less affected during 96 to 144 weeks. For patients switched from TDF to TMF, a substantial further increase in the alanine aminotransferase (ALT) normalization rate was observed (11.4%), along with improved FIB-4 scores.Conclusion:After 144 weeks of TMF treatment, CHB patients achieved high rates of virological, serological, and biochemical responses, as well as improved liver fibrosis outcomes. Also, switching to TMF resulted in significant benefits in ALT normalization rates (NCT03903796).
9.Safety profile of tenofovir amibufenamide therapy extension or switching in patients with chronic hepatitis B: a phase Ⅲ multicenter, randomized controlled trial
Zhihong LIU ; Qinglong JIN ; Yuexin ZHANG ; Guozhong GONG ; Guicheng WU ; Lvfeng YAO ; Xiaofeng WEN ; Zhiliang GAO ; Yan HUANG ; Daokun YANG ; Enqiang CHEN ; Qing MAO ; Shide LIN ; Jia SHANG ; Huanyu GONG ; Lihua ZHONG ; Huafa YIN ; Fengmei WANG ; Peng HU ; Xiaoqing ZHANG ; Qunjie GAO ; Peng XIA ; Chuan LI ; Junqi NIU ; Jinlin HOU
Chinese Journal of Hepatology 2024;32(10):893-903
Objective:In chronic hepatitis B (CHB) patients with previous 96-week treatment with tenofovir amibufenamide (TMF) or tenofovir disoproxil fumarate (TDF), we investigated the safety profile of sequential TMF treatment from 96 to 144 weeks.Methods:Enrolled subjects that previously assigned (2:1) to receive either 25 mg TMF or 300 mg TDF with matching placebo for 96 weeks received extending or switching TMF treatment for 48 weeks. Safety profiles of kidney, bone, metabolism, body weight, and others were evaluated.Results:666 subjects from the initial TMF group and 336 subjects from TDF group with at least one dose of assigned treatment were included at week 144. The overall safety profile was favorable in each group and generally similar between extended or switched TMF treatments from week 96 to 144. In subjects switching from TDF to TMF, the non-indexed estimated glomerular filtration rate (by non-indexed CKD-EPI formula) and creatinine clearance (by Cockcroft-Gault formula) were both increased, which were (2.31±8.33) ml/min and (4.24±13.94) ml/min, respectively. These changes were also higher than those in subjects with extending TMF treatment [(0.91±8.06) ml/min and (1.30±13.94) ml/min]. Meanwhile, switching to TMF also led to an increase of the bone mineral density (BMD) by 0.75% in hip and 1.41% in spine. On the other side, a slight change in TC/HDL ratio by 0.16 (IQR: 0.00, 0.43) and an increase in body mass index (BMI) by (0.54±0.98) kg/m 2 were oberved with patients switched to TMF, which were significantly higher than that in TMF group. Conclusion:CHB patients receiving 144 weeks of TMF treatment showed favorable safety profile. After switching to TMF, the bone and renal safety was significantly improved in TDF group, though experienceing change in metabolic parameters and weight gain (NCT03903796).
10.A Review of the Current Status and Progress Scope of Defensive Medical Research in China
Huanyu ZHANG ; Xinle YIN ; Yue ZHOU ; Yaping LIU ; Lin WU ; Yajie FENG ; Libo LIANG
Chinese Hospital Management 2024;44(7):1-5
Objective Summarizes the current research status of defensive medicine in China and provides references for future research.Methods The search period spans from the inception of the database to March 2024.CNKI,Wan-fang Data,Web of Science,PubMed databases were queried,followed by literature screening based on predeter-mined inclusion and exclusion criteria.The current landscape of defensive medicine research in China was synthe-sized and categorized based on fundamental research characteristics,measurement methodologies,influencing fac-tors,and other relevant aspects.Results A total of 24 Chinese literature sources and 4 foreign literature sources were incorporated,indicating a prevalent occurrence of defensive medicine in China.Measurement tools for defen-sive medicine exhibit variability across different studies.Key influencing factors encompass doctor's demographic vari-ables such as gender,age,and professional status,institutional factors like legal frameworks and medical in-surance,and sociol-cultural factors such as doctor-patient relationships and adverse public perceptions.Conclusion Defensive medicine is relatively widespread and influenced by various factors in China.It's urgent to explore the for-mation mechanism of defensive medicine from multiple perspectives and provide evidence for passive defen-sive medicine governance.


Result Analysis
Print
Save
E-mail